Xylazine Wound Care Clinic and Protocol

Xylazine Wound Care Clinic and Protocol

People who use drugs across the United States are reporting a novel type of wound associated with the fentanyl-adulterant veterinary sedative, xylazine. While the mechanism behind wound formation has yet to be fully described, traditional wound science with a harm reduction approach can be effectively utilized to guide care for people who use drugs who develop wounds. This presentation leverages the experience of a low-barrier, nurse-led clinic in Kensington, Philadelphia, PA, which remains the epicenter of the xylazine epidemic, to describe evidence-informed practices for assessing and treating xylazine-associated wounds while responding to the real-world needs and challenges of a criminalized and socially alienated population. 

Learn More and Register 

For trainings that indicate Continuing Education Units (CEUs) are available, contact your licensing or certification organization to verify that the credits will count toward the continuing education requirements